{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:43:50Z","timestamp":1792100630359,"version":"4.4.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.celrep.2026.117910","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:10:16Z","timestamp":1787850616000},"page":"117910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combined type 2 cytokine blockade enhances PD-1-mediated antitumor immunity"],"prefix":"10.1016","volume":"45","author":[{"given":"Thomas","family":"Fabre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanore","family":"Hendrickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"McGourty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola M.","family":"Marcovecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Patti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KaiLi","family":"Cage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Searles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christella","family":"Widjaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Stairiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Bound","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Pyszczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel A.","family":"Stoner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Ching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Wynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.S.","family":"Barron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Richard L.","family":"Gieseck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.117910_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(16)32517-X","article-title":"Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial","volume":"389","author":"Rittmeyer","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2026.117910_bib2","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after Chemoradiotherapy in Stage III Non\u2013Small-Cell Lung Cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117910_bib3","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus Chemotherapy for PD-L1\u2013Positive Non\u2013Small-Cell Lung Cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117910_bib4","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117910_bib5","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ccell.2020.08.005","article-title":"Conserved Interferon-\u03b3 Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma","volume":"38","author":"Grasso","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117910_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar3342","article-title":"MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma","volume":"10","author":"Rodig","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2026.117910_bib7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117910_bib8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117910_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ccell.2020.03.017","article-title":"Acquired Resistance to Immune Checkpoint Inhibitors","volume":"37","author":"Schoenfeld","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117910_bib10","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S1470-2045(19)30407-3","article-title":"Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis","volume":"20","author":"Antonia","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.celrep.2026.117910_bib11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117910_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41586-020-2134-y","article-title":"A conserved dendritic-cell regulatory program limits antitumour immunity","volume":"580","author":"Maier","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117910_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1399-0039.2007.00831.x","article-title":"The duplicitous effects of interleukin 4 on tumour immunity: how can the same cytokine improve or impair control of tumour growth","volume":"69","author":"Olver","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.celrep.2026.117910_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-023-06797-9","article-title":"An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis","volume":"625","author":"LaMarche","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117910_bib15","first-page":"1594","article-title":"Expression of IL-4 and IL-13 predicts recurrence and survival in localized clear-cell renal cell carcinoma","volume":"8","author":"Chang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.celrep.2026.117910_bib16","doi-asserted-by":"crossref","first-page":"6360S","DOI":"10.1158\/1078-0432.CCR-050011","article-title":"Effect of Renal Cell Carcinomas on the Development of Type 1 T-Cell Responses","volume":"10","author":"Rayman","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117910_bib17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2340\/00015555-3201","article-title":"Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis","volume":"99","author":"Fowler","year":"2019","journal-title":"Acta Derm. Venerol."},{"key":"10.1016\/j.celrep.2026.117910_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri.2017.90","article-title":"Type 2 immunity in tissue repair and fibrosis","volume":"18","author":"Gieseck","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev-immunol-101320-030339","article-title":"Emerging Paradigms in Type 2 Immunity","volume":"40","author":"Hammad","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib20","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1073\/pnas.90.13.5914","article-title":"Interleukin 4 suppresses interleukin 2 and interferon gamma production by naive T cells stimulated by accessory cell-dependent receptor engagement","volume":"90","author":"Tanaka","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117910_bib21","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1084\/jem.170.5.1751","article-title":"Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells","volume":"170","author":"Peleman","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117910_bib22","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.4049\/jimmunol.162.5.2663","article-title":"Enhanced cytotoxic T cell activity in IL-4-deficient mice","volume":"162","author":"Villacres","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib23","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.4049\/jimmunol.167.11.6497","article-title":"Tumor-Specific Tc1, But Not Tc2, Cells Deliver Protective Antitumor Immunity","volume":"167","author":"Kemp","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/intimm\/dxl019","article-title":"IL-4 influences the differentiation and the susceptibility to activation-induced cell death of human naive CD8+ T cells","volume":"18","author":"Riou","year":"2006","journal-title":"Int. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)80240-8","article-title":"The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells","volume":"89","author":"Zheng","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117910_bib26","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/380630a0","article-title":"Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted State6 gene","volume":"380","author":"Shimoda","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117910_bib27","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/380627a0","article-title":"Essential role of Stat6 in IL-4 signalling","volume":"380","author":"Takeda","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117910_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1084\/jem.192.1.105","article-title":"Gata-3 Induces T Helper Cell Type 2 (Th2) Cytokine Expression and Chromatin Remodeling in Committed Th1 Cells","volume":"192","author":"Lee","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117910_bib29","doi-asserted-by":"crossref","first-page":"724","DOI":"10.4049\/jimmunol.167.2.724","article-title":"Enforced Expression of GATA-3 in Transgenic Mice Inhibits Th1 Differentiation and Induces the Formation of a T1\/ST2-Expressing Th2-Committed T Cell Compartment In Vivo","volume":"167","author":"Nawijn","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib30","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/ni1128","article-title":"Conditional deletion of Gata3 shows its essential function in TH1-TH2 responses","volume":"5","author":"Zhu","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jaci.2023.01.023","article-title":"Severe allergic dysregulation due to a gain of function mutation in the transcription factor STAT6","volume":"152","author":"Baris","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib32","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221755","article-title":"Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease","volume":"220","author":"Sharma","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117910_bib33","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1084\/jem.185.5.817","article-title":"Regulation of the Interleukin (IL)-12R \u03b22 Subunit Expression in Developing T Helper 1 (Th1) and Th2 Cells","volume":"185","author":"Szabo","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117910_bib34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.immuni.2011.08.007","article-title":"Genome-wide Analyses of Transcription Factor GATA3-Mediated Gene Regulation in Distinct T Cell Types","volume":"35","author":"Wei","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117910_bib35","doi-asserted-by":"crossref","first-page":"17876","DOI":"10.1073\/pnas.0909357106","article-title":"The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes","volume":"106","author":"Jenner","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117910_bib36","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00262-017-2043-6","article-title":"IL-4 blockade alters the tumor microenvironment and augments the response to cancer immunotherapy in a mouse model","volume":"66","author":"Ito","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2026.117910_bib37","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.20022227","article-title":"Transforming Growth Factor-\u03b2 Production and Myeloid Cells Are an Effector Mechanism through Which CD1d-restricted T Cells Block Cytotoxic T Lymphocyte\u2013mediated Tumor Immunosurveillance","volume":"198","author":"Terabe","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117910_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2009.06.018","article-title":"CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages","volume":"16","author":"DeNardo","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117910_bib39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1101\/gad.1874010","article-title":"IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion","volume":"24","author":"Gocheva","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2026.117910_bib40","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.celrep.2026.117910_bib41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4049\/jimmunol.178.1.219","article-title":"Comparative Roles of IL-4, IL-13, and IL-4R\u03b1 in Dendritic Cell Maturation and CD4+ Th2 Cell Function","volume":"178","author":"Webb","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib42","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.jaci.2020.11.036","article-title":"Mast cell\u2013derived IL-13 downregulates IL-12 production by skin dendritic cells to inhibit the TH1 cell response to cutaneous antigen exposure","volume":"147","author":"Leyva-Castillo","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib43","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.4049\/jimmunol.165.11.6015","article-title":"Cutting Edge: STAT6-Deficient Mice Have Enhanced Tumor Immunity to Primary and Metastatic Mammary Carcinoma","volume":"165","author":"Ostrand-Rosenberg","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib44","doi-asserted-by":"crossref","first-page":"5796","DOI":"10.4049\/jimmunol.169.10.5796","article-title":"Resistance to Metastatic Disease in STAT6-Deficient Mice Requires Hemopoietic and Nonhemopoietic Cells and Is IFN-\u03b3 Dependent","volume":"169","author":"Ostrand-Rosenberg","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib45","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/82771","article-title":"NKT cell\u2013mediated repression of tumor immunosurveillance by IL-13 and the IL-4R\u2013STAT6 pathway","volume":"1","author":"Terabe","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib46","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.4049\/jimmunol.165.11.6024","article-title":"Spontaneous Rejection of Poorly Immunogenic P1.HTR Tumors by Stat6-Deficient Mice","volume":"165","author":"Kacha","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib47","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1158\/2326-6066.CIR-22-0547","article-title":"Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti\u2013PD-1 in Metastatic Non\u2013Small Cell Lung Cancer","volume":"11","author":"He","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.celrep.2026.117910_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj7002","article-title":"Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity","volume":"8","author":"Kamerkar","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2026.117910_bib49","doi-asserted-by":"crossref","first-page":"636","DOI":"10.4049\/jimmunol.174.2.636","article-title":"Reduction of Myeloid-Derived Suppressor Cells and Induction of M1 Macrophages Facilitate the Rejection of Established Metastatic Disease","volume":"174","author":"Sinha","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib50","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/carcin\/bgq044","article-title":"Epithelial interleukin-4 receptor expression promotes colon tumor growth","volume":"31","author":"Koller","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.celrep.2026.117910_bib51","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41577-022-00735-y","article-title":"Role of thymic stromal lymphopoietin in allergy and beyond","volume":"23","author":"Ebina-Shibuya","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib52","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1084\/jem.20090153","article-title":"TSLP and IL-7 use two different mechanisms to regulate human CD4+ T cell homeostasis","volume":"206","author":"Lu","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117910_bib53","doi-asserted-by":"crossref","first-page":"19455","DOI":"10.1073\/pnas.1008271107","article-title":"Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7\u2013induced signaling","volume":"107","author":"Rochman","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117910_bib54","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1165\/rcmb.2008-0041OC","article-title":"Functional Analysis of the Thymic Stromal Lymphopoietin Variants in Human Bronchial Epithelial Cells","volume":"40","author":"Harada","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.celrep.2026.117910_bib55","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.4049\/jimmunol.1302175","article-title":"Cutting Edge: Identification of the Thymic Stromal Lymphopoietin\u2013Responsive Dendritic Cell Subset Critical for Initiation of Type 2 Contact Hypersensitivity","volume":"191","author":"Kitajima","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib56","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jaci.2014.05.010","article-title":"A thymic stromal lymphopoietin\u2013responsive dendritic cell subset mediates allergic responses in the upper airway mucosa","volume":"134","author":"Melum","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib57","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.20051135","article-title":"TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand","volume":"202","author":"Ito","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117910_bib58","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ni805","article-title":"Human epithelial cells trigger dendritic cell\u2013mediated allergic inflammation by producing TSLP","volume":"3","author":"Soumelis","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib59","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1084\/jem.20150402","article-title":"TSLP-activated dendritic cells induce human T follicular helper cell differentiation through OX40-ligand","volume":"214","author":"Pattarini","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117910_bib60","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41385-020-0266-x","article-title":"Targeted deletion of the TSLP receptor reveals cellular mechanisms that promote type 2 airway inflammation","volume":"13","author":"Kabata","year":"2020","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib61","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jaci.2020.03.032","article-title":"TSLP drives acute TH2-cell differentiation in lungs","volume":"146","author":"Lai","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib62","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1084\/jem.20030240","article-title":"Human Dendritic Cells Activated by TSLP and CD40L Induce Proallergic Cytotoxic T Cells","volume":"197","author":"Gilliet","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117910_bib63","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20101876","article-title":"Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer","volume":"208","author":"Monte","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117910_bib64","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1084\/jem.20102131","article-title":"Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation","volume":"208","author":"Pedroza-Gonzalez","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117910_bib65","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1158\/0008-5472.CAN-15-1801-T","article-title":"Basophil Recruitment into Tumor-Draining Lymph Nodes Correlates with Th2 Inflammation and Reduced Survival in Pancreatic Cancer Patients","volume":"76","author":"De Monte","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2026.117910_bib66","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ccr.2012.08.016","article-title":"Loss of Cutaneous TSLP-Dependent Immune Responses Skews the Balance of Inflammation from Tumor Protective to Tumor Promoting","volume":"22","author":"Di Piazza","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117910_bib67","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ccr.2012.08.017","article-title":"Elevated Epidermal Thymic Stromal Lymphopoietin Levels Establish an Antitumor Environment in the Skin","volume":"22","author":"Demehri","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117910_bib68","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1172\/JCI83724","article-title":"Thymic stromal lymphopoietin blocks early stages of breast carcinogenesis","volume":"126","author":"Demehri","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2026.117910_bib69","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1084\/jem.20181952","article-title":"Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs","volume":"216","author":"Mastio","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117910_bib70","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1158\/0008-5472.CAN-14-1482","article-title":"Tumor-Derived Osteopontin Suppresses Antitumor Immunity by Promoting Extramedullary Myelopoiesis","volume":"74","author":"Kim","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2026.117910_bib71","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3\u2013related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2026.117910_bib72","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.ccell.2022.11.002","article-title":"Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop","volume":"40","author":"Hua","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117910_bib73","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg7836","article-title":"A reservoir of stem-like CD8+ T cells in the tumor-draining lymph node preserves the ongoing anti-tumor immune response","volume":"6","author":"Connolly","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib74","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.immuni.2021.08.026","article-title":"Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+ CD8+ T cells in tumor-draining lymph nodes","volume":"54","author":"Schenkel","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117910_bib75","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib76","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1073\/pnas.1718217115","article-title":"Role of PD-1 during effector CD8 T cell differentiation","volume":"115","author":"Ahn","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.celrep.2026.117910_bib77","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1172\/JCI40040","article-title":"PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice","volume":"120","author":"Mueller","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2026.117910_bib78","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ccell.2020.09.001","article-title":"The PD-1\/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes","volume":"38","author":"Dammeijer","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117910_bib79","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s43018-020-0075-x","article-title":"PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer","volume":"1","author":"Oh","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.celrep.2026.117910_bib80","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1038\/s41467-020-18570-x","article-title":"PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade","volume":"11","author":"Peng","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117910_bib81","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.4049\/jimmunol.170.3.1257","article-title":"Blockade of Programmed Death-1 Ligands on Dendritic Cells Enhances T Cell Activation and Cytokine Production","volume":"170","author":"Brown","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib82","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.immuni.2022.12.002","article-title":"CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor","volume":"56","author":"Prokhnevska","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117910_bib83","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.cell.2019.08.009","article-title":"Fate Mapping via Ms4a3-Expression History Traces Monocyte-Derived Cells","volume":"178","author":"Liu","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117910_bib84","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.immuni.2012.10.016","article-title":"Conventional and Monocyte-Derived CD11b+ Dendritic Cells Initiate and Maintain T Helper 2 Cell-Mediated Immunity to House Dust Mite Allergen","volume":"38","author":"Plantinga","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117910_bib85","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.4049\/jimmunol.1102744","article-title":"CD64 Expression Distinguishes Monocyte-Derived and Conventional Dendritic Cells and Reveals Their Distinct Role during Intramuscular Immunization","volume":"188","author":"Langlet","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib86","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1084\/jem.20160600","article-title":"Mafb lineage tracing to distinguish macrophages from other immune lineages reveals dual identity of Langerhans cells","volume":"213","author":"Wu","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117910_bib87","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.4049\/jimmunol.1701514","article-title":"Tumor Dendritic Cells (DCs) Derived from Precursors of Conventional DCs Are Dispensable for Intratumor CTL Responses","volume":"201","author":"Diao","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib88","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI128267","article-title":"Antigen-loaded monocyte administration induces potent therapeutic anti-tumor T cell responses","volume":"130","author":"Huang","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2026.117910_bib89","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cell.2010.09.039","article-title":"Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN\/CD209+ Dendritic Cells for Immune T Cell Areas","volume":"143","author":"Cheong","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117910_bib90","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41586-020-2611-3","article-title":"cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity","volume":"584","author":"Ferris","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117910_bib91","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41423-024-01133-1","article-title":"CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors","volume":"21","author":"Lei","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.celrep.2026.117910_bib92","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41467-022-35615-5","article-title":"CD4+ helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment","volume":"14","author":"Lei","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117910_bib93","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ccell.2014.09.007","article-title":"Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity","volume":"26","author":"Broz","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117910_bib94","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.immuni.2017.10.009","article-title":"CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness","volume":"47","author":"Ahrends","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117910_bib95","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jdin.2024.01.002","article-title":"A real-world study of dupilumab in patients with atopic dermatitis including patients with malignancy and other medical comorbidities","volume":"15","author":"Metko","year":"2024","journal-title":"JAAD Int."},{"key":"10.1016\/j.celrep.2026.117910_bib96","article-title":"Real-Life Safety and Effectiveness of Dupilumab in Patients with Concomitant Malignancies: a Case Series","volume":"13","author":"Gargiulo","year":"2023","journal-title":"Dermatol. Pract. Concept."},{"key":"10.1016\/j.celrep.2026.117910_bib97","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3390\/jcm12031191","article-title":"Treatment of Severe Atopic Dermatitis with Dupilumab in Patients with Advanced Cancer","volume":"12","author":"Tanczosova","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.celrep.2026.117910_bib98","doi-asserted-by":"crossref","first-page":"e651","DOI":"10.1111\/jdv.17264","article-title":"Atopic dermatitis, dupilumab and cancers: a case series","volume":"35","author":"Siliquini","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.celrep.2026.117910_bib99","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/life12101670","article-title":"Atopic Dermatitis with Multiple Comorbidities Treated with Dupilumab. A Case Report and Review of the Literature Regarding the Safety of Dupilumab","volume":"12","author":"Mitroi","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.celrep.2026.117910_bib100","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s40264-017-0636-9","article-title":"Potential Risks Related to Modulating Interleukin-13 and Interleukin-4 Signalling: A Systematic Review","volume":"41","author":"Braddock","year":"2018","journal-title":"Drug Saf."},{"key":"10.1016\/j.celrep.2026.117910_bib101","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2340\/00015555-3208","article-title":"Diagnosis of Mycosis Fungoides Following Administration of Dupilumab for Misdiagnosed Atopic Dermatitis","volume":"99","author":"Chiba","year":"2019","journal-title":"Acta Derm. Venerol."},{"key":"10.1016\/j.celrep.2026.117910_bib102","doi-asserted-by":"crossref","first-page":"adv00271","DOI":"10.2340\/00015555-3576","article-title":"Dupilumab Treatment in Two Patients with Cutaneous T-cell Lymphomas","volume":"100","author":"Lazaridou","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.celrep.2026.117910_bib103","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaad.2020.03.050","article-title":"Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patients","volume":"83","author":"Espinosa","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.celrep.2026.117910_bib104","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/mps7020020","article-title":"A Simple and Rapid Protocol for the Isolation of Murine Bone Marrow Suitable for the Differentiation of Dendritic Cells","volume":"7","author":"Song","year":"2024","journal-title":"Methods Protoc."},{"key":"10.1016\/j.celrep.2026.117910_bib105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12864-019-6344-3","article-title":"Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors","volume":"21","author":"Zhong","year":"2020","journal-title":"BMC Genom."},{"key":"10.1016\/j.celrep.2026.117910_bib106","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The Immune Landscape of Cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726009885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726009885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:43:49Z","timestamp":1792097029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726009885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":106,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2211124726009885"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117910","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined type 2 cytokine blockade enhances PD-1-mediated antitumor immunity","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117910"}}